ALDX - Company ID 0001341235
Aldeyra Therapeutics, Inc. trades as ALDX. This page tracks Aldeyra Therapeutics, Inc. through 629 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-01 |
| Annual report to shareholders | ARS | 2026-04-27 |
| Proxy materials | DEFA14A | 2026-04-27 |
| Proxy statement | DEF 14A | 2026-04-27 |
| Major company event | 8-K | 2026-04-20 |
| Major company event | 8-K | 2026-04-01 |
The largest companies sharing Aldeyra Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Aldeyra Therapeutics, Inc. reported a net loss of $33.85M.